描述

An allograft is tissue that is transplanted from one person to another. Soft tissue allografts are an important substitute tissue for the reconstruction of deficient ligaments, torn menisci, and osteochondral defects during knee surgery. Interest in allografts for soft tissue reconstruction has arisen from the demand to obtain a stable knee with restoration of function and protection against additional injury. The global soft tissue allografts market is set to increase by US$ 1,892.4 百万来自 2022 到 2028, 代表复合年增长率 (复合年增长率) 的 5.7% 在预测期内.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for soft tissue allografts. The global soft tissue allografts market is segmented on the basis of product, 应用, 最终用户, 和地区. 根据产品, the global soft tissue allografts market has been segmented into amniotic allografts, cartilage allografts, dental allografts, meniscus allografts, tendon allografts, 其他的. The cartilage allografts segment is estimated to account for the largest share of the global soft tissue allografts market. 按申请, the global soft tissue allografts market has been segmented into dentistry, orthopedic, wound care, 其他的. The dentistry segment held the largest revenue share in 2021. Based on end user, the global soft tissue allografts market is categorized into hospitals, aesthetic centers, 诊所, 其他的. 从地理上来说, the global soft tissue allografts market has been segmented into Asia Pacific, 欧洲, 北美, 世界其他地区 (排). North America was the largest contributor to the global soft tissue allografts market in 2021.

The global soft tissue allografts market is highly competitive. The key players in the soft tissue allografts market include Allosource Inc., Arthrex Inc., 格洛布斯医疗公司, Integra LifeSciences Corporation, 约翰逊 & 约翰逊, MiMedx Group Inc., Organogenesis Inc., SeaSpine Holdings Corporation, Straumann Holding AG, Zimmer Biomet 控股公司.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the soft tissue allografts market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

产品: amniotic allografts, cartilage allografts, dental allografts, meniscus allografts, tendon allografts, 其他的
应用: dentistry, orthopedic, wound care, 其他的
最终用户: 医院, aesthetic centers, 诊所, 其他的
地区: 亚太地区, 欧洲, 北美, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global soft tissue allografts market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Soft tissue allografts market overview
部分 3. 按产品划分的市场细分
– Amniotic allografts
– Cartilage allografts
– Dental allografts
– Meniscus allografts
– Tendon allografts
– 其他的
部分 4. 按应用划分的市场细分
– Dentistry
– Orthopedic
– Wound care
– 其他的
部分 5. 按最终用户划分的市场细分
– 医院
– Aesthetic centers
– 诊所
– 其他的
部分 6. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)
部分 7. 重点企业
– Allosource Inc.
– Arthrex Inc.
– Globus Medical, 公司.
– Integra LifeSciences Corporation
– 约翰逊 & 约翰逊
– MiMedx Group Inc.
– Organogenesis, 公司.
– SeaSpine Holdings Corporation
– Straumann Holding AG
– Zimmer Biomet Holdings, 公司.
关于StrategyHelix
免责声明